C4 Therapeutics, Inc. · NASDAQ:CCCC

Orbimed Advisors LLC reported a 6.60% stake in C4 Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Orbimed Advisors LLC reported a 6.60% stake in C4 Therapeutics, Inc., 4,655,600 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
6.60%
Shares
4,655,600
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC3.10%2,174,700
OrbiMed Capital LLC6.60%4,655,600

Source

View original at SEC

Related